Integrative microarray analysis of pathways dysregulated in metastatic prostate cancer

Area of Science:

• Oncology
• Bioinformatics
• Molecular Biology

Background:

• Microarrays are crucial for identifying genes in cancer progression.
• Existing methods often require predefined gene expression thresholds, limiting pathway analysis.
• Prostate cancer metastasis involves complex genetic alterations.

Purpose of the Study:

• To develop and validate a novel algorithm for identifying dysregulated pathways from multiple microarray datasets without predefined thresholds.
• To identify key dysregulated pathways in prostate cancer metastasis using this new approach.
• To validate the identified pathways at both transcript and protein levels.

Main Methods:

• Developed an algorithm named Integrative Microarray Analysis of Pathways (IMAP).
• Applied IMAP to analyze existing expression array data from localized and metastatic prostate cancer.
• Validated the most significantly dysregulated pathway (HIV-I NEF) using quantitative PCR and immunohistochemistry.
• Confirmed findings using unsupervised analysis on an independent dataset.

Main Results:

• IMAP identified approximately 100 significantly dysregulated pathways (P < 0.05) in prostate cancer metastasis.
• The HIV-I NEF pathway exhibited the most significant dysregulation.
• Transcript and protein levels of the HIV-I NEF pathway were validated.
• Independent dataset analysis confirmed the accuracy of the IMAP method.

Conclusions:

• The IMAP algorithm effectively identifies dysregulated pathways in cancer metastasis without requiring prior gene expression thresholds.
• The HIV-I NEF pathway is a key player in prostate cancer metastasis, especially in hormone-refractory cases.
• This study provides a robust method for pathway analysis in cancer research and identifies a potential therapeutic target.